In recent years, mRNA in lipid nanoparticles (mRNA–LNPs) has emerged as a promising strategy for treating numerous conditions ...
Metabolic dysfunction-associated steatotic liver disease (MASLD) can cause more serious liver conditions, such as liver failure. A new study, led by Lund University in Sweden, presents new data that ...
MASLD is present in over 70% of outpatients with type 2 diabetes. In addition, a 2-tier screening approach is useful for liver fibrosis stratification.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results